Xvivo Perfusion AB Stock
Stocks
XVIVO
SE0004840718
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 213.60 SEK | -4.47% |
|
-9.64% | +14.47% |
| 09-30 | Xvivo Perfusion nomination committee unchanged | FW |
| 09-29 | Aggregate short positions on the Stockholm Stock Exchange as of September 29 | FW |
| Market Cap | 7.04B 702M 624M 582M 530M 1B 67.47B 1.01B 2.73B 34.49B 2.64B 2.58B 111B | P/E 2026 * |
73.4x | P/E 2027 * | 38.7x |
|---|---|---|---|---|---|
| Enterprise Value | 6.94B 692M 614M 574M 523M 986M 66.48B 995M 2.69B 33.99B 2.6B 2.54B 109B | EV / Sales 2026 * |
7.01x | EV / Sales 2027 * | 5.51x |
| Free-Float |
77.41% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| XVIVO | Delayed | |
CBOE
| XVIVOs | Real-time | |
|
OTC Markets
| XVIPF | Delayed | |
|
London S.E.
| 0RKL | Delayed | |
|
Boerse Muenchen
| 3XV | Real-time | |
|
CBOE
| 0RKL | Real-time | |
|
Börse Stuttgart
| 3XV | Delayed | |
|
Deutsche Boerse AG
| 3XV | Delayed |
Last Transcript: Xvivo Perfusion AB
| 1 day | -4.20% | ||
| 1 week | -9.64% | ||
| Current month | -3.00% | ||
| 1 month | -18.72% | ||
| 3 months | -18.16% | ||
| 6 months | -11.07% | ||
| Current year | +14.47% |
| 1 week | 213.6 |  | 246.4 |
| 1 month | 213.6 | | 271.6 |
| Current year | 171.8 | | 314.8 |
| 1 year | 160 | | 314.8 |
| 3 years | 160 | | 547 |
| 5 years | 127.8 | | 547 |
| 10 years | 67.5 | | 547 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2022-09-26 | |
| Director of Finance/CFO | 41 | 2020-11-30 | |
Lena Hagman
COO | Chief Operating Officer | 61 | 2022-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 2018-04-26 | |
Camilla Öberg
BRD | Director/Board Member | 62 | 2016-04-30 |
Goran Dellgren
BRD | Director/Board Member | 65 | 2021-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/26 | Buy | Director | 1,643 | 0.0052% | ||
| 7/21/26 | Buy | Director | 2,007 | 0.0064% | ||
| 3/20/26 | Buy | Chief Financial Officer | 300 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.47% | -9.64% | +30.16% | -20.45% | 701M | |
| +0.40% | -4.60% | -27.34% | +0.95% | 167B | |
| +0.86% | -1.80% | -8.83% | +11.93% | 111B | |
| +1.05% | +1.01% | -24.91% | +0.47% | 105B | |
| -1.24% | -0.76% | -49.04% | -12.75% | 74.82B | |
| -0.69% | +0.05% | -0.48% | +71.48% | 59.11B | |
| -0.86% | +4.49% | +17.49% | +57.78% | 51.8B | |
| -1.02% | -4.30% | -8.18% | -31.75% | 48.5B | |
| +0.52% | +0.08% | -18.01% | +20.59% | 40.79B | |
| -1.00% | -1.66% | +28.21% | -9.91% | 32.54B | |
| Average | -0.61% | -0.74% | -6.09% | +8.83% | 69.09B | |
| Weighted average by Cap. | +0.06% | -0.92% | -16.13% | +9.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 990M 98.61M 87.61M 81.77M 74.53M 141M 9.48B 142M 383M 4.85B 370M 362M 15.55B | 1.26B 126M 112M 104M 94.94M 179M 12.07B 181M 488M 6.17B 472M 461M 19.81B |
| Net income | 95.97M 9.56M 8.5M 7.93M 7.23M 13.63M 919M 13.76M 37.19M 470M 35.91M 35.13M 1.51B | 182M 18.16M 16.13M 15.06M 13.72M 25.88M 1.75B 26.12M 70.61M 892M 68.17M 66.69M 2.86B |
| Net Debt | -103M -10.24M -9.1M -8.49M -7.74M -14.6M -984M -14.73M -39.82M -503M -38.44M -37.61M -1.61B | -101M -10.06M -8.94M -8.34M -7.61M -14.35M -967M -14.48M -39.13M -495M -37.78M -36.96M -1.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | SEK 213.60 | -4.47% | 101,835 |
| 26-10-01 | SEK 223.60 | +1.54% | 68,287 |
| 26-09-30 | SEK 220.20 | -1.96% | 189,510 |
| 26-09-29 | SEK 224.60 | -5.63% | 251,119 |
| 26-09-28 | SEK 238.00 | +0.68% | 178,725 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- XVIVO Stock
Select your edition
All financial news and data tailored to specific country editions
